Delivery Order SPE2DB22D1103-SPE2DB25FH2S6
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 13, 2025, valued at $1,201.20 for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used to...
- The Defense Logistics Agency awarded a delivery order valued at $3,527.97 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems as part of comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens valued at $10,644.05 on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $5,044.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems supported...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $3,713.49. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was made on a competitive basis. Trulicity is a brand-name diabetes...
- The Defense Logistics Agency awarded a delivery order valued at $4,155.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) with an ultimate completion date of April 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly...
- The Defense Logistics Agency awarded a $13,827.64 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 3 mg/0.5 ml pens with a completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized across military and federal healthcare systems. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,594.55 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on September 4, 2025, with completion targeted for September 5, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH2S6Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,351.35 on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems supported through DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the delivery of a broad range of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/19/25 |